COVINA, CA -- (MARKET WIRE) -- September 08, 2006 -- Healtheuniverse, Inc. (PINKSHEETS: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, announced today that the Company’s fat based stem cell technology is moving to clinical trials without the use of human embryonic stem cells. The Company is preparing to submit an application through an Independent Institutional Review Board to pursue our clinical trial for the utilization of fat based stem cells. Using this approach provides the promise of stem cell medical breakthroughs while avoiding the controversy surrounding destruction of embryos.
